StockData
AVAIOTCServices-Computer Processing & Data PreparationFiscal year ends March 31

AVAI BIO, INC.

Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$0.11−0.00 (-1.75%)

Close on Oct 19, 2026

Market cap
$17.24M
P/E (TTM)
–
Dividend yield
–

AVAI BIO, INC. revenue by segment

No segment breakdown reported

Avai Bio does not break out revenue by segment, region or product in the tagged data of its filings for this period type.